Spinal Cord Stimulation Combined With Motor Imagery Brain-Computer Interface for Chronic Post-Stroke Upper Limb Motor Dysfunction

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorZhejiang Provincial People's Hospital

About this trial

This clinical study aims to evaluate the efficacy and safety of spinal cord stimulation combined with non-invasive motor imagery brain-computer interface rehabilitation training in patients with upper limb motor dysfunction after chronic stroke. The study includes an experimental group receiving spinal cord stimulation combined with motor imagery brain-computer interface rehabilitation training and a control group receiving motor imagery brain-computer interface rehabilitation training alone. The primary outcome is upper limb motor function assessed by the Fugl-Meyer Assessment for Upper Extremity. Secondary outcomes include muscle tone, upper limb functional activity, activities of daily living, adverse events, serious adverse events, and exploratory neurophysiological and neuroimaging indicators.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 18 to 75 years.

First-ever unilateral supratentorial stroke, either ischemic or hemorrhagic, confirmed by computed tomography or magnetic resonance imaging, resulting in hemiparesis, with disease duration longer than 6 months.

At least one active movement in the wrist or fingers of the affected upper limb, with muscle strength of grade 1 or higher.

Fugl-Meyer Assessment for Upper Extremity score between 10 and 40, indicating moderate upper limb motor impairment.

Disqualifiers

Other neurological diseases that may cause motor dysfunction, such as Parkinson's disease, multiple sclerosis, or spinal cord injury.

Severe visual or auditory impairment that prevents cooperation with visual or auditory feedback instructions of the brain-computer interface system.

Contraindications to spinal cord stimulation surgery, such as severe coagulation dysfunction, infection at the puncture site, severe spinal deformity, or spinal canal stenosis.

History of epilepsy, intracranial metal implants, cardiac pacemaker, or other contraindications to magnetic resonance imaging.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Spinal Cord Stimulation

    Device

    Spinal cord stimulation will be delivered through epidural electrodes implanted at cervical spinal cord levels, typically C3-C7 for upper limb dysfunction. Stimulation parameters will be individually optimized within clinically safe and device-permitted ranges, including frequency, pulse width, amplitude, electrode configuration, and stimulation mode.

  • Motor Imagery Brain-Computer Interface Rehabilitation Training

    Device

    Motor imagery brain-computer interface training will use a 64-channel medical-grade electroencephalography cap to acquire scalp EEG signals. Participants will perform motor imagery tasks involving the affected upper limb, such as grasping, elbow extension, or wrist lifting. Sensorimotor rhythm features, especially mu rhythm and beta rhythm event-related desynchronization, will be extracted in real time. When significant event-related desynchronization is detected, the system will trigger external feedback, such as a soft robotic glove or functional electrical stimulation, to assist the affected limb in completing the target movement.

Treatment groups

66 Participants
are divided into 2 treatment groups
Group A: Spinal Cord Stimulation Combined With Motor Imagery Brain-Computer Interface TrainingExperimental treatment 2 interventions
Group B: Motor Imagery Brain-Computer Interface Rehabilitation TrainingActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in Fugl-Meyer Assessment for Upper Extremity Score

The Fugl-Meyer Assessment for Upper Extremity will be used to evaluate motor function recovery of the affected upper limb.

Time frame
Baseline, Week 4, Week 8, and Week 12

Secondary outcomes

1

Change in Modified Ashworth Scale Score

The Modified Ashworth Scale will be used to assess muscle tone and spasticity of the affected upper limb.

Time frame
Baseline, Week 4, Week 8, and Week 12
2

Change in Action Research Arm Test Score

The Action Research Arm Test will be used to assess functional activity of the affected upper limb, including grasp, grip, pinch, and gross movement.

Time frame
Baseline, Week 4, Week 8, and Week 12
3

Change in Modified Barthel Index Score

The Modified Barthel Index will be used to assess activities of daily living.

Time frame
Baseline, Week 4, Week 8, and Week 12
4

Incidence of Adverse Events and Serious Adverse Events

All adverse events and serious adverse events will be recorded and assessed throughout the study. Spinal cord stimulation-related adverse events may include intraoperative or postoperative bleeding, infection, cerebrospinal fluid leakage, electrode migration or fracture, implant rejection, postoperative pain, and neurological injury. Motor imagery brain-computer interface-related adverse events may include dizziness, visual fatigue, skin allergy related to electrode gel, training-related fatigue, and other discomfort.

Time frame
From enrollment to Week 12

Other outcomes

1

Change in Electroencephalographic Indicators

Resting-state and motor imagery task-state 64-channel electroencephalography will be collected to analyze event-related desynchronization/synchronization, phase-lag-index-based functional connectivity, and graph-theoretical topological properties.

Time frame
Baseline, Week 4, and Week 12
2

Change in Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging Indicators

Resting-state functional magnetic resonance imaging and diffusion tensor imaging will be performed to assess changes in functional connectivity of the default mode network and sensorimotor network, as well as fractional anisotropy and mean diffusivity of major white matter tracts, including the corticospinal tract.

Time frame
Baseline and Week 12

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: